IDEXX Laboratories, Inc.
IDXX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $4 | $4 | $3 | $3 |
| % Growth | 6.5% | 8.7% | 4.7% | – |
| Cost of Goods Sold | $2 | $1 | $1 | $1 |
| Gross Profit | $2 | $2 | $2 | $2 |
| % Margin | 61% | 59.8% | 59.5% | 58.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $1 | $1 | $1 | $1 |
| % Margin | 29% | 30% | 26.7% | 29% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $1 | $1 | $1 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1 | $1 | $1 | $1 |
| % Margin | 22.8% | 23.1% | 20.2% | 23.2% |
| EPS | 10.77 | 10.17 | 8.12 | 8.74 |
| % Growth | 5.9% | 25.2% | -7.1% | – |
| EPS Diluted | 10.67 | 10.06 | 8.03 | 8.6 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 32.7% | 33.3% | 30.1% | 32.3% |